Article Examines Economic Burden of Pediatric Asthma

An article in the October 2018 edition of PharmacoEconomics examined the economic burden of pediatric asthma. Researchers conducted a literature review of articles “reporting on healthcare resource utilization and/or healthcare costs of pediatric asthma.” After reviewing the articles, researchers found “costs for children with asthma were significantly greater than for children without,” and “pediatric asthma imposes a significant economic burden to the US healthcare system.” They also noted pharmacy, inpatient, and outpatient costs were “the primary contributors to healthcare costs.”

To view the article’s abstract, click here.

Share